Category:
Active Pharmaceutical Ingredients
CAS NO:
1207456-01-6
Standard:
In-house Standards,
Oncology Breast Cancer
Talazoparib (BMN 673) is a potent PARP inhibitor developed for oncology. Its core synthesis involves advanced heterocyclic coupling. Molecular formula: C20H19FN4O3; CAS No.: 1210385-67-7.
Strictly store at controlled room temperature away from moisture. Handle with PPE due to potential genotoxicity. Contraindicated in severe hepatic impairment without dose adjustment protocols.